Probiotics May Reduce Chemotherapy Side Effects in Breast Cancer Patients
Emerging research suggests that multi-strain probiotics may help reduce common chemotherapy side effects such as fatigue and nausea in breast cancer patients, improving quality of life during treatment.
Chemotherapy remains a cornerstone in breast cancer treatment, renowned for its effectiveness in combating cancer cells. However, it also comes with significant side effects, including fatigue, weakness, and heightened vulnerability to infections, which can impact patients' quality of life and treatment adherence. Recent research highlights the potential role of probiotics as a supportive supplement during chemotherapy.
A study published in the open-access journal Pharmacia investigated the impact of multi-strain probiotics on chemotherapy-related side effects in breast cancer patients. The study tracked improvements in symptoms such as fatigue and nausea, showing that probiotic supplementation—comprising seven different bacterial strains—could alleviate these common adverse effects both before and after treatment.
In addition to symptom relief, the research found that probiotics helped improve blood urea nitrogen levels, which are linked to kidney function and overall metabolic health. Patients also experienced greater independence in their daily activities, likely due to reduced fatigue and nausea. These findings suggest that certain probiotic strains may support immune function and overall well-being during intensive cancer therapies.
Despite promising results, researchers emphasize the need for larger-scale studies to confirm these benefits and determine the most effective probiotic formulations. Incorporating probiotics into standard cancer care could, in the future, offer a safe and accessible way to mitigate side effects and enhance patient quality of life during chemotherapy.
Source: https://medicalxpress.com/news/2025-05-probiotic-supplementation-chemotherapy-side-effects.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Study Finds Tumor-Related Epilepsy Is Not a Major Prognostic Indicator in Diffuse Glioma Patients
New research indicates that tumor-related epilepsy does not serve as a significant prognostic factor in patients with diffuse gliomas, highlighting complex tumor-brain interactions affecting outcomes.
Healthcare Professionals Face Challenges Maintaining Empathy in High-Pressure Environments, Says New Research
A recent study from Umeå University reveals that time pressures, education structures, and workplace culture challenge healthcare professionals in maintaining empathy, emphasizing the need for systemic support to foster better patient care.
Innovative Low-Cost Drug Formulation Enhances Treatment for Parasitic Worms
A groundbreaking, affordable drug formulation improves efficacy against parasitic worms, reducing doses and facilitating global treatment efforts. Developed with nanotechnology, this innovation promises better accessibility for those affected by helminth infections worldwide.